Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 841 to 845 of 845 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: Computed tomography osteoabsorptiometry-based investigation on subchondral bone plate alterations in sacroiliac joint dysfunction.

Scientific reports

Poilliot A, Doyle T, Kurosawa D, Toranelli M, Zhang M, Zwirner J, Müller-Gerbl M, Hammer N.
PMID: 34341472
Sci Rep. 2021 Aug 02;11(1):16033. doi: 10.1038/s41598-021-95570-x.

No abstract available.

Cite
Poilliot A, Doyle T, Kurosawa D, et al. Publisher Correction: Computed tomography osteoabsorptiometry-based investigation on subchondral bone plate alterations in sacroiliac joint dysfunction. Sci Rep. 2021;11(1):16033doi: 10.1038/s41598-021-95570-x.
Poilliot, A., Doyle, T., Kurosawa, D., Toranelli, M., Zhang, M., Zwirner, J., Müller-Gerbl, M., & Hammer, N. (2021). Publisher Correction: Computed tomography osteoabsorptiometry-based investigation on subchondral bone plate alterations in sacroiliac joint dysfunction. Scientific reports, 11(1), 16033. https://doi.org/10.1038/s41598-021-95570-x
Poilliot, A, et al. "Publisher Correction: Computed tomography osteoabsorptiometry-based investigation on subchondral bone plate alterations in sacroiliac joint dysfunction." Scientific reports vol. 11,1 (2021): 16033. doi: https://doi.org/10.1038/s41598-021-95570-x
Poilliot A, Doyle T, Kurosawa D, Toranelli M, Zhang M, Zwirner J, Müller-Gerbl M, Hammer N. Publisher Correction: Computed tomography osteoabsorptiometry-based investigation on subchondral bone plate alterations in sacroiliac joint dysfunction. Sci Rep. 2021 Aug 02;11(1):16033. doi: 10.1038/s41598-021-95570-x. PMID: 34341472; PMCID: PMC8329173.
Copy Download .nbib Format: NLM
Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy.

Current oncology (Toronto, Ont.)

Sofuni A, Asai Y, Tsuchiya T, Ishii K, Tanaka R, Tonozuka R, Honjo M, Mukai S, Nagai K, Yamamoto K, Matsunami Y, Kurosawa T, Kojima H, Homma T, Minami H, Nakatsubo R, Hirakawa N, Miyazawa H, Nagakawa Y, Tsuchida A, Itoi T.
PMID: 34898585
Curr Oncol. 2021 Nov 20;28(6):4845-4861. doi: 10.3390/curroncol28060409.

High-intensity focused ultrasound (HIFU) is a novel advanced therapy for unresectable pancreatic cancer (PC). HIFU therapy with chemotherapy is being promoted as a novel method to control local advancement by tumor ablation. We evaluated the therapeutic effects of HIFU...

Cite
Sofuni A, Asai Y, Tsuchiya T, et al. Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy. Curr Oncol. 2021;28(6):4845-4861doi: 10.3390/curroncol28060409.
Sofuni, A., Asai, Y., Tsuchiya, T., Ishii, K., Tanaka, R., Tonozuka, R., Honjo, M., Mukai, S., Nagai, K., Yamamoto, K., Matsunami, Y., Kurosawa, T., Kojima, H., Homma, T., Minami, H., Nakatsubo, R., Hirakawa, N., Miyazawa, H., Nagakawa, Y., Tsuchida, A., & Itoi, T. (2021). Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy. Current oncology (Toronto, Ont.), 28(6), 4845-4861. https://doi.org/10.3390/curroncol28060409
Sofuni, Atsushi, et al. "Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy." Current oncology (Toronto, Ont.) vol. 28,6 (2021): 4845-4861. doi: https://doi.org/10.3390/curroncol28060409
Sofuni A, Asai Y, Tsuchiya T, Ishii K, Tanaka R, Tonozuka R, Honjo M, Mukai S, Nagai K, Yamamoto K, Matsunami Y, Kurosawa T, Kojima H, Homma T, Minami H, Nakatsubo R, Hirakawa N, Miyazawa H, Nagakawa Y, Tsuchida A, Itoi T. Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy. Curr Oncol. 2021 Nov 20;28(6):4845-4861. doi: 10.3390/curroncol28060409. PMID: 34898585.
Copy Download .nbib Format: NLM
Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation.

JMA journal

Matsuda K, Kurokawa M.
PMID: 33225110
JMA J. 2020 Oct 15;3(4):357-358. doi: 10.31662/jmaj.2020-0072. Epub 2020 Oct 02.

No abstract available.

Cite
Matsuda K, Kurokawa M. Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation. JMA J. 2020;3(4):357-358doi: 10.31662/jmaj.2020-0072.
Matsuda, K., & Kurokawa, M. (2020). Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation. JMA journal, 3(4), 357-358. https://doi.org/10.31662/jmaj.2020-0072
Matsuda, Kensuke, and Kurokawa, Mineo. "Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation." JMA journal vol. 3,4 (2020): 357-358. doi: https://doi.org/10.31662/jmaj.2020-0072
Matsuda K, Kurokawa M. Underlying Disease and Clinical Phenotypes of Disseminated Intravascular Coagulation. JMA J. 2020 Oct 15;3(4):357-358. doi: 10.31662/jmaj.2020-0072. Epub 2020 Oct 02. PMID: 33225110; PMCID: PMC7677011.
Copy Download .nbib Format: NLM
Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up.

Journal of cancer survivorship : research and practice

Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Mori T, Tanaka M, Kondo T, Umemoto Y, Goto H, Yoshioka S, Machida S, Sato T, Katayama Y, Kato S, Shono K, Mizuno I, Fujiwara SI, Kohno A, Takahashi M, Fukuda T.
PMID: 34449050
J Cancer Surviv. 2021 Aug 27; doi: 10.1007/s11764-021-01092-w. Epub 2021 Aug 27.

PURPOSE: To characterize the issues regarding work and employment specific to allogeneic hematopoietic cell transplantation (allo-HCT) survivors, we conducted a nationwide cross-sectional questionnaire survey.METHODS: We targeted allo-HCT survivors employed at diagnosis, aged 20-64 at survey, and survived ≥2 years...

Cite
Kurosawa S, Yamaguchi T, Mori A, et al. Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. J Cancer Surviv. 2021;doi: 10.1007/s11764-021-01092-w.
Kurosawa, S., Yamaguchi, T., Mori, A., Matsuura, T., Mori, T., Tanaka, M., Kondo, T., Umemoto, Y., Goto, H., Yoshioka, S., Machida, S., Sato, T., Katayama, Y., Kato, S., Shono, K., Mizuno, I., Fujiwara, S. I., Kohno, A., Takahashi, M., & Fukuda, T. (2021). Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. Journal of cancer survivorship : research and practice, . https://doi.org/10.1007/s11764-021-01092-w
Kurosawa, Saiko, et al. "Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up." Journal of cancer survivorship : research and practice vol. (2021). doi: https://doi.org/10.1007/s11764-021-01092-w
Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Mori T, Tanaka M, Kondo T, Umemoto Y, Goto H, Yoshioka S, Machida S, Sato T, Katayama Y, Kato S, Shono K, Mizuno I, Fujiwara SI, Kohno A, Takahashi M, Fukuda T. Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. J Cancer Surviv. 2021 Aug 27; doi: 10.1007/s11764-021-01092-w. Epub 2021 Aug 27. PMID: 34449050.
Copy Download .nbib Format: NLM
Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree.

Journal of applied toxicology : JAT

Imai N, Takeyoshi M, Aizawa S, Tsurumaki M, Kurosawa M, Toyoda A, Sugiyama M, Kasahara K, Ogata S, Omori T, Hirota M.
PMID: 34927266
J Appl Toxicol. 2021 Dec 19; doi: 10.1002/jat.4275. Epub 2021 Dec 19.

Demands for the elimination and replacement of animal experiments for cosmetic safety assessment have increased in recent years. Evaluation of skin sensitization, however, is a critical issue in cosmetic safety assessment. The SH test is an in vitro skin...

Cite
Imai N, Takeyoshi M, Aizawa S, et al. Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree. J Appl Toxicol. 2021;doi: 10.1002/jat.4275.
Imai, N., Takeyoshi, M., Aizawa, S., Tsurumaki, M., Kurosawa, M., Toyoda, A., Sugiyama, M., Kasahara, K., Ogata, S., Omori, T., & Hirota, M. (2021). Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree. Journal of applied toxicology : JAT, . https://doi.org/10.1002/jat.4275
Imai, Noriyasu, et al. "Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree." Journal of applied toxicology : JAT vol. (2021). doi: https://doi.org/10.1002/jat.4275
Imai N, Takeyoshi M, Aizawa S, Tsurumaki M, Kurosawa M, Toyoda A, Sugiyama M, Kasahara K, Ogata S, Omori T, Hirota M. Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree. J Appl Toxicol. 2021 Dec 19; doi: 10.1002/jat.4275. Epub 2021 Dec 19. PMID: 34927266.
Copy Download .nbib Format: NLM
Showing 841 to 845 of 845 entries